Cardiovascular risk factors may return to pre-treatment levels, potentially increasing the risk of heart disease, stroke, and other cardiovascular complications
This creates situations where patients cannot choose their pharmacy and have limited recourse when problems occur
The FDA is conducting a safety review to examine real-world reports, but this is a precautionary investigation, not confirmation of causation
No trial enrolled her into one
Ubiquinol Acetate Carnipure L-carnitine L-tartrate Lycopene Astaxanthin With Zinc Tablets Ingredients: Sodium Selenate Anhydrous Eq
Any concerns about medication tolerability, unexpected symptoms, or questions about blood pressure management should be discussed with the healthcare team rather than discontinuing therapy independently